APO RESEARCH · REPORT
Micafungin Sodium for Injection
Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.
Product & engineering
Understand the product.
Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.
Selected research
Industry Research
Micafungin Sodium for Injection Industry Research Report 2026
Market perspective
Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.
North America is the largest Micafungin Sodium for Injection market with about 28% market share. Europe is follower, accounting for about 26% market share.
The key players are Astellas etc. Astellas occupied about 97% market share.
Read the full market overview
Report Scope
This report quantifies the global Micafungin Sodium for Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Micafungin Sodium for Injection Market by Company
Astellas
Micafungin Sodium for Injection Segment by Type
50 mg Single-use Vial
100 mg Single-use Vial
Micafungin Sodium for Injection Segment by Application
Candidemia
Respiratory Mycosis
Gastrointestinal Mycosis
Micafungin Sodium for Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Micafungin Sodium for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Micafungin Sodium for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Micafungin Sodium for Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Micafungin Sodium for Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Micafungin Sodium for Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Micafungin Sodium for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 50 mg Single-use Vial
- 100 mg Single-use Vial
Applications
- Candidemia
- Respiratory Mycosis
- Gastrointestinal Mycosis
Companies covered
- Astellas
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Micafungin Sodium for Injection Market Size (2021-2032)
- 2.2.2 Global Micafungin Sodium for Injection Sales (2021-2032)
- 2.2.3 Global Micafungin Sodium for Injection Market Average Price (2021-2032)
- 2.3 Micafungin Sodium for Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 50 mg Single-use Vial
- 2.3.3 100 mg Single-use Vial
- 2.4 Micafungin Sodium for Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Candidemia
- 2.4.3 Respiratory Mycosis
- 2.4.4 Gastrointestinal Mycosis
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Micafungin Sodium for Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Micafungin Sodium for Injection Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Micafungin Sodium for Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Micafungin Sodium for Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Micafungin Sodium for Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Micafungin Sodium for Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Micafungin Sodium for Injection, Product Type & Application
- 3.8 Global Manufacturers of Micafungin Sodium for Injection, Established Date
- 3.9 Global Micafungin Sodium for Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Astellas
- 4.1.1 Astellas Company Information
- 4.1.2 Astellas Business Overview
- 4.1.3 Astellas Micafungin Sodium for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Astellas Micafungin Sodium for Injection Product Portfolio
- 4.1.5 Astellas Recent Developments
5 Global Micafungin Sodium for Injection Market Scenario by Region
- 5.1 Global Micafungin Sodium for Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Micafungin Sodium for Injection Sales by Region: 2021-2032
- 5.2.1 Global Micafungin Sodium for Injection Sales by Region: 2021-2026
- 5.2.2 Global Micafungin Sodium for Injection Sales by Region: 2027-2032
- 5.3 Global Micafungin Sodium for Injection Revenue by Region: 2021-2032
- 5.3.1 Global Micafungin Sodium for Injection Revenue by Region: 2021-2026
- 5.3.2 Global Micafungin Sodium for Injection Revenue by Region: 2027-2032
- 5.4 North America Micafungin Sodium for Injection Market Facts & Figures by Country
- 5.4.1 North America Micafungin Sodium for Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Micafungin Sodium for Injection Sales by Country (2021-2032)
- 5.4.3 North America Micafungin Sodium for Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Micafungin Sodium for Injection Market Facts & Figures by Country
- 5.5.1 Europe Micafungin Sodium for Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Micafungin Sodium for Injection Sales by Country (2021-2032)
- 5.5.3 Europe Micafungin Sodium for Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Micafungin Sodium for Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Micafungin Sodium for Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Micafungin Sodium for Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Micafungin Sodium for Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Micafungin Sodium for Injection Market Facts & Figures by Country
- 5.7.1 South America Micafungin Sodium for Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Micafungin Sodium for Injection Sales by Country (2021-2032)
- 5.7.3 South America Micafungin Sodium for Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Micafungin Sodium for Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Micafungin Sodium for Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Micafungin Sodium for Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Micafungin Sodium for Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Micafungin Sodium for Injection Sales by Type (2021-2032)
- 6.1.1 Global Micafungin Sodium for Injection Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Micafungin Sodium for Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Micafungin Sodium for Injection Revenue by Type (2021-2032)
- 6.2.1 Global Micafungin Sodium for Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Micafungin Sodium for Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Micafungin Sodium for Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Micafungin Sodium for Injection Sales by Application (2021-2032)
- 7.1.1 Global Micafungin Sodium for Injection Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Micafungin Sodium for Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Micafungin Sodium for Injection Revenue by Application (2021-2032)
- 7.2.1 Global Micafungin Sodium for Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Micafungin Sodium for Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Micafungin Sodium for Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Micafungin Sodium for Injection Value Chain Analysis
- 8.1.1 Micafungin Sodium for Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Micafungin Sodium for Injection Production Mode & Process
- 8.2 Micafungin Sodium for Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Micafungin Sodium for Injection Distributors
- 8.2.3 Micafungin Sodium for Injection Customers
9 Global Micafungin Sodium for Injection Analyzing Market Dynamics
- 9.1 Micafungin Sodium for Injection Industry Trends
- 9.2 Micafungin Sodium for Injection Industry Drivers
- 9.3 Micafungin Sodium for Injection Industry Opportunities and Challenges
- 9.4 Micafungin Sodium for Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst